Oliver Schoor,Andrea Mahr,Toni Weinschenk,Anita Wiebe,Jens Fritsche,Harpreet Singh
申请号：
US15979089
公开号：
US10442844B2
申请日:
2018.05.14
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T-cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
